140 related articles for article (PubMed ID: 37553484)
1. Therapeutic applications of local injection of hsa-miR-634 into canine spontaneous malignant melanoma tumors.
Yoshikawa R; Inoue J; Iwasaki R; Terauchi M; Fujii Y; Ohta M; Hasegawa T; Mizuno R; Mori T; Inazawa J
Cancer Gene Ther; 2023 Nov; 30(11):1524-1529. PubMed ID: 37553484
[TBL] [Abstract][Full Text] [Related]
2. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
3. LINC01296 promotes proliferation of cutaneous malignant melanoma by regulating miR-324-3p/MAPK1 axis.
Wang K; Luo Q; Zhang Y; Xie X; Cheng W; Yao Q; Chen Y; Ren H; Li J; Pan Z
Aging (Albany NY); 2022 Dec; 15(8):2877-2890. PubMed ID: 36462499
[TBL] [Abstract][Full Text] [Related]
4. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
Su BB; Zhou SW; Gan CB; Zhang XN
J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
[TBL] [Abstract][Full Text] [Related]
5. MiR-186 inhibits cell proliferation and invasion in human cutaneous malignant melanoma.
Su BB; Zhou SW; Gan CB; Zhang XN
J Cancer Res Ther; 2018; 14(Supplement):S60-S64. PubMed ID: 29578151
[TBL] [Abstract][Full Text] [Related]
6. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
[TBL] [Abstract][Full Text] [Related]
7. LINC00518 affects the proliferation, invasion and migration of cutaneous malignant melanoma cells via miR-526b-3p/EIF5A2 axis.
Xu J; Zhang F; Lin M; Tong Y
Acta Biochim Pol; 2022 Feb; 69(1):101-111. PubMed ID: 35189053
[TBL] [Abstract][Full Text] [Related]
8. Coordinated targeting of MMP-2/MMP-9 by miR-296-3p/FOXCUT exerts tumor-suppressing effects in choroidal malignant melanoma.
Wang X; Hu Y; Cui J; Zhou Y; Chen L
Mol Cell Biochem; 2018 Aug; 445(1-2):25-33. PubMed ID: 29260433
[TBL] [Abstract][Full Text] [Related]
9. lncRNA TINCR attenuates the proliferation and invasion, and enhances the apoptosis of cutaneous malignant melanoma cells by regulating the miR‑424‑5p/LATS1 axis.
Han X; Jia Y; Chen X; Sun C; Sun J
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34542165
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
Bai J; Zhang Z; Li X; Liu H
Int J Clin Exp Pathol; 2015; 8(5):4913-22. PubMed ID: 26191184
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma.
Long J; Menggen Q; Wuren Q; Shi Q; Pi X
Med Sci Monit; 2018 Mar; 24():1547-1559. PubMed ID: 29543785
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation contributes toward silencing of antioncogenic microRNA-203 in human and canine melanoma cells.
Noguchi S; Mori T; Nakagawa T; Itamoto K; Haraguchi T; Mizuno T
Melanoma Res; 2015 Oct; 25(5):390-8. PubMed ID: 26225581
[TBL] [Abstract][Full Text] [Related]
13. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
14. Loss of MiR-664 Expression Enhances Cutaneous Malignant Melanoma Proliferation by Upregulating PLP2.
Ding Z; Jian S; Peng X; Liu Y; Wang J; Zheng L; Ou C; Wang Y; Zeng W; Zhou M
Medicine (Baltimore); 2015 Aug; 94(33):e1327. PubMed ID: 26287415
[TBL] [Abstract][Full Text] [Related]
15. Synthetic microRNA-205 exhibited tumour suppression in spontaneous canine malignant melanoma by intratumoral injection.
Yoshikawa R; Mori T; Noguchi S; Akao Y; Maruo K; Kitade Y
Vet Comp Oncol; 2019 Sep; 17(3):407-412. PubMed ID: 31020761
[TBL] [Abstract][Full Text] [Related]
16. miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapy.
Tang H; Ma M; Dai J; Cui C; Si L; Sheng X; Chi Z; Xu L; Yu S; Xu T; Yan J; Yu H; Yang L; Kong Y; Guo J
J Exp Clin Cancer Res; 2019 May; 38(1):212. PubMed ID: 31118065
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
Bai J; Zhang Z; Li X; Liu H
Cancer Biomark; 2015; 15(5):599-608. PubMed ID: 26406949
[TBL] [Abstract][Full Text] [Related]
18. miR-4262 promotes the proliferation of human cutaneous malignant melanoma cells through KLF6-mediated EGFR inactivation and p21 upregulation.
Zhang D; Li Z; Zhang Y; Tu C; Huo J; Liu Y
Oncol Rep; 2016 Dec; 36(6):3657-3663. PubMed ID: 27779691
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1.
Cirilo PDR; de Sousa Andrade LN; Corrêa BRS; Qiao M; Furuya TK; Chammas R; Penalva LOF
BMC Cancer; 2017 Nov; 17(1):750. PubMed ID: 29126391
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-182 Suppresses Malignant Melanoma Proliferation by Targeting RECK.
Ding J; Zhu X; Chen X; Guan J; Li H
Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
